ADVANCED HEALTH INTELLIGENCE LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.092 AUD | +8.24% |
|
-.--% | -26.40% |
| 04-18 | Advanced Health Intelligence's Loss Widens in H1 FY2024 | MT |
| 04-18 | Advanced Health Intelligence Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 20.01 | 45.72 | 22.6 | - |
| Enterprise Value (EV) 1 | 20.01 | 45.72 | 22.6 | 22.6 |
| P/E ratio | - | - | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | 33.4 x | 59.2 x | 2.48 x | 0.57 x |
| EV / Revenue | 33.4 x | 59.2 x | 2.48 x | 0.57 x |
| EV / EBITDA | -1.66 x | -3.87 x | -7.41 x | 1.2 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 166,749 | 217,704 | 245,653 | - |
| Reference price 2 | 0.1200 | 0.2100 | 0.0920 | 0.0920 |
| Announcement Date | 22-08-31 | 23-08-31 | - | - |
1AUD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.5984 | 0.7722 | 9.112 | 39.65 |
| EBITDA 1 | - | -12.06 | -11.8 | -3.05 | 18.77 |
| EBIT 1 | - | -21.13 | -15.1 | -3.45 | 18.37 |
| Operating Margin | - | -3,530.94% | -1,955.28% | -37.86% | 46.34% |
| Earnings before Tax (EBT) 1 | - | -21.46 | -15.32 | -3.531 | 18.32 |
| Net income 1 | -14.06 | -20.57 | -13.3 | -2.472 | 12.83 |
| Net margin | - | -3,437.78% | -1,722.83% | -27.13% | 32.35% |
| EPS | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 21-08-31 | 22-08-31 | 23-08-31 | - | - |
1AUD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.2981 | 0.3003 | 0.5207 | 0.2515 | 8.462 | 19.65 | 20 |
| EBITDA 1 | -11.02 | -7.49 | - | - | 2.045 | 9.274 | 9.5 |
| EBIT 1 | -13.31 | -7.82 | -5.152 | -9.946 | 1.845 | 9.074 | 9.3 |
| Operating Margin | -4,464.55% | -2,604.14% | -989.5% | -3,954.92% | 21.8% | 46.18% | 46.5% |
| Earnings before Tax (EBT) 1 | -15.36 | -6.101 | -5.116 | -10.21 | 1.743 | 8.972 | 9.35 |
| Net income 1 | -14.47 | -6.101 | -3.906 | -9.397 | 1.22 | 6.281 | 6.545 |
| Net margin | -4,854.49% | -2,031.4% | -750.18% | -3,736.71% | 14.42% | 31.96% | 32.73% |
| EPS | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 22-02-28 | 22-08-31 | 23-02-28 | 23-08-31 | - | - | - |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 21-08-31 | 22-08-31 | 23-08-31 | - | - |
1AUD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.40% | 14.86M | |
| -2.24% | 27.47B | |
| +4.41% | 2.47B | |
| +105.03% | 2.11B | |
| -22.47% | 1.92B | |
| -49.03% | 1.49B | |
| +11.97% | 1.39B | |
| -15.09% | 1.33B | |
| +3.88% | 1.33B | |
| +14.05% | 1.16B |
- Stock Market
- Equities
- AHI Stock
- Financials Advanced Health Intelligence Ltd